The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The outbreak of COVID-19 brought the mRNA technology to light. From a silent long-term technology that needed to prove its potential, well behind other technologies like C&G therapies, to the focus of everyone's attention. Lead by Moderna, BioNTech and CureVac the number of players in this field is growing rapidly. New starts-up as well as establish pharmaceutical companies are now turning to mRNA. What are the exciting applications for mRNA technology beyond the COVID-19 vaccine? The goal of this session is to explore the potential of mRNA applications from vaccines to personalized medicines and beyond as a catalysator for such transformation.